TrialBMC complementary medicine and therapies2024

The hepatorenal protective effects of silymarin in cancer patients receiving chemotherapy: a randomized, placebo-controlled trial.

Safoora Sadat Erfanian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.